These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2867105)

  • 21. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
    Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD
    J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method for identification of the peptides that bind to a clone of thyroid-stimulating antibodies in the serum of Graves' disease patients.
    Na CH; Lee MH; Cho BY; Chae CB
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1570-6. PubMed ID: 12679441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease.
    Paschke R; Vogg M; Kristoferitsch R; Aktuna D; Wawschinek O; Eber O; Usadel KH
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2470-4. PubMed ID: 7629244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable regions of Ig heavy chain genes encoding antithyrotropin receptor antibodies of patients with Graves' disease.
    Shin EK; Akamizu T; Matsuda F; Sugawa H; Fujikura J; Mori T; Honjo T
    J Immunol; 1994 Feb; 152(3):1485-92. PubMed ID: 8301147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follow up of Graves' patients thyroid stimulating antibody activity during treatment. A prospective study.
    Bakó G; Lenkey A; Szabó T; Karanyi Z; Forizs E; Kálmán K; Szabó J; Varvölgyi C; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):600-4. PubMed ID: 2894709
    [No Abstract]   [Full Text] [Related]  

  • 26. Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices.
    Laurent E; Van Sande J; Ludgate M; Corvilain B; Rocmans P; Dumont JE; Mockel J
    J Clin Invest; 1991 May; 87(5):1634-42. PubMed ID: 1673689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
    Kahaly G; Grübl M; Moncayo R; Schilling S; Weber P; Beyer J; Krause U
    Dev Ophthalmol; 1989; 20():68-78. PubMed ID: 2574117
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR; Saunders NB; Kaulfersch W; Burman KD
    J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detectability of antibodies directed against different thyroid structures by indirect immunofluorescence, with Graves' patients' sera. A prospective study.
    Szabo J; Forizs E; Bako G; Mezösi E; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):590-5. PubMed ID: 2894708
    [No Abstract]   [Full Text] [Related]  

  • 30. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease.
    Hargreaves CE; Grasso M; Hampe CS; Stenkova A; Atkinson S; Joshua GW; Wren BW; Buckle AM; Dunn-Walters D; Banga JP
    J Immunol; 2013 Jun; 190(11):5373-81. PubMed ID: 23630351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathogenesis of Graves' disease.
    Gossage AA; Munro DS
    Clin Endocrinol Metab; 1985 May; 14(2):299-330. PubMed ID: 2866051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
    Yokoyama N; Izumi M; Katamine S; Nagataki S
    J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients.
    Tamai H; Kasagi K; Takaichi Y; Takamatsu J; Komaki G; Matsubayashi S; Konishi J; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1989 Jul; 69(1):49-53. PubMed ID: 2471711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of Epstein-Barr-virus-transformed lymphocytes producing IgG class monoclonal antibodies using a magnetic cell separator (MACS): preparation of thyroid-stimulating IgG antibodies from patients with Graves' disease.
    Li H; Akamizu T; Okuda J; Sugawa H; Matsuda F; Tsubata T; Mori T
    Biochem Biophys Res Commun; 1995 Feb; 207(3):985-93. PubMed ID: 7864905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexistence of thyroid-stimulating and thyroid-blocking antibodies in a patient with Graves' disease who had transient hypothyroidism.
    Miyauchi A; Amino N; Tamaki H; Kuma K
    Am J Med; 1988 Sep; 85(3):418-20. PubMed ID: 2901227
    [No Abstract]   [Full Text] [Related]  

  • 37. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Bucci I; Carpentieri M; Di Nenno B; Di Blasio A; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1080-7. PubMed ID: 22492869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease.
    Paschke R; Vogg M; Swillens S; Usadel KH
    J Clin Endocrinol Metab; 1993 Oct; 77(4):939-43. PubMed ID: 8408468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.